Radiotherapy versus follow-up in the treatment of pathological stage Ia and Ib non-small cell lung cancer. Early stopped analysis of a randomized controlled study

European Journal of Cardio-thoracic Surgery

Volumn 18, Issue 4, 2000, Pages 418-424

  Granone, Pierluigi ^a   Trodella, Lucio ^b   Margaritora, Stefano ^a   Cesario, Alfredo ^a   Corbo, Giuseppe Maria ^b   Mantini, Giovanna ^b   Balducci, Mario ^b   Fumagalli, Giorgio ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Adjuvant radiotherapy; Early stage; Non small cell lung cancer; Randomized study; Surgery

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION PNEUMONIA; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS;

EID: 0034307931     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(00)00539-X     Document Type: Article

References (37)

1. Mountain C.F. Revisions in the International System for staging lung cancer. Chest. 111:1997;1710-1717.
2. Mountain C.F. A new international staging system for lung cancer. Chest. 89s:1986;225-233.
3. Gail M.H., Eagan R., Feld R., Ginsberg R., Goodell B., Hill L., Holmes E.C., Lukeman J.M., Mountain C.F., Oldham R.K. Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer. 54:1984;1802-1813.
4. Lipford E.H., Egglestone J.C., Lillemoe K.D., Sears D.L., Moore G.W., Baker R.R. Prognostic factors in surgically resected, limited stage, non-small cell carcinoma of the lung. Am J Surg Pathol. 8:(5):1984;357-365.
5. Martini N., Beattie E.J. Results of surgical treatment in stage I lung cancer. J Thorac Cardiovasc Surg. 74:1977;499-505.
6. Pairolero P.C., Williams D.E., Bergstralh E.J., Pihler J.M., Bernatz P.E., Payne W.S. Post-surgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg. 38:(4):1984;331-338.
7. Thomas P., Rubinstein L. Cancer recurrence after resection: T1N0 non small cell lung cancer. Ann Thorac Surg. 49:1990;242-247.
8. Sorensen J.B., Badsberg J.H. Prognostic factors in resected stages I and II adenocarcinoma of the lung. J Thorac Cardiovasc Surg. 99:1990;218-226.
9. Thomas P.A., Rubinstein L. Malignant disease appearing late after operation for T1N0 non small cell lung cancer. J Thorac Cardiovasc Surg. 106:1993;1053-1058.
10. Ichinose Y., Yano T., Yokoyama H., Inoue T., Asoh H., Tayama K., Takanishi N. Post recurrent survival of patients with non small cell lung cancer undergoing a complete resection. J Thorac Cardiovasc Surg. 108:1994;158-161.
11. Yano T., Yokoyama H., Inoue T., Tayama K., Takai E., Ichinose Y. The first site of recurrence after complete resection in non small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 108:(4):1994;680-683.
12. Harpole D.H., Herndon J.E., Young W.G., Wolfe W.G., Sabiston D.C. Stage I non small cell lung cancer. Cancer. 76:1995;787-796.
13. Martini N., Bains M.S., Burt M.E., Zakowski M.F., McCormack P., Rusch V.W., Ginsberg R.J. Incidence of local recurrence and second primary tumours in resected stage I lung cancer. J Thorac Cardiovasc Surg. 109:1995;120-129.
14. Cangemi V., Volpino P., D'Andrea N., Puopolo M., Fabrizi S., Leonardo M.T., Piat G. Local and/or distant recurrences in T1-2/N0-1 non small cell lung cancer. Eur J Cardio-thorac Surg. 9:1995;473-478.
15. Martini N., Rusch V.W., Bains M.S., Kris M.G., Downey R.J., Flehinger B.J., Ginsberg R.J. Factors influencing ten year survival in resected stages I to IIIa non small cell lung cancer. J Thorac Cardiovasc Surg. 117:1999;32-38.
16. Wingo P.A., Tong T., Bolden S. Cancer statistics 1994. CA Cancer J Clin. 45:1995;8-30.
17. Van Houtte O., Rocmans P., Smets P. Post-operative radiation therapy in lung cancer: a controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys. 6:1980;983-986.
18. Lafitte J.J., Ribert M.E., Prevost B.M., Gosselin B.H., Brichet A.H. Post-resection irradiation for T2N0M0 non small cell carcinoma: a prospective, randomized study. Ann Thorac Surg. 62:1996;830-834.
19. Philips P., Rocmans P., Vanderhoeft P., Van Houtte P. Post-operative radiotherapy after pneumonectomy: impact of modern treatment facilities. Int J Radiat Oncol Biol Phys. 27:1993;525-529.
20. Emami B., Kaiser L., Simpson J., Shapiro S., Roper C., Lockett M.A. Postoperative radiation therapy in non small cell lung cancer. Am J Clin Oncol. 20:(5):1997;441-448.
21. Post-operative radiotherapy in non small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled studies. Lancet. 352:1998;257-263.
22. Kramer A. Sample size determination in clinical trials. Clinical trials statistics for non statisticians. 1998;EORTC, Brussels.
23. Pocock S.J. Interim analysis for randomized clinical trials: the group sequential approach. Biometrika. 64:1977;191-199.
24. Pocock S.J. Interim analysis for randomized clinical trials: the group sequential approach. Biometrics. 38:1982;153-162.
25. Pocock S.J. Statistical and ethical issues in monitoring clinical trials. Stat Med. 12:1993;1459-1469.
26. O'Brien P.C., Fleming T.R. A multiple testing procedure for clinical trials. Biometrics. 35:1979;549-556.
27. McPherson K. Interim analysis and stopping rules. Buyse M., Stagnet M., Sylvester R. Cancer clinical trials: methods and practice. 1984;Oxford Medical Publishing, Oxford.
28. Kaplan-Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
29. Anderson R.P., Bonchek L.I., Grunkemeier G.L., Lambert R.E., Starr A. The analysis and presentation of surgical results by actuarial methods. J Surg Res. 16:1974;224-230.
30. Randomized trial of lobectomy versus limited resection for T1N0 NSCLC. Ann Thorac Surg. 60:1995;615-623.
31. Ginsberg R.J. Resection of non small cell lung cancer. How much and by what route. Chest. 112:(1):1997;203S-205S.
32. Izbicky J.R., Passlick B., Pantel K., Piehemeier V., Hosch S.B., Karg O., Thetter O. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non small cell lung cancer. Ann Surg. 227:1998;138-144.
33. Munro A. What now for post-operative radiotherapy for lung cancer. Lancet. 352:1998;250-252.
34. Byhardt R.W., Martin L., Pajak T.F., Shink H., Emami B., Cox J.D. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable NSCLC. Analysis of a radiation therapy oncology group (RTOG) protocol. Int J Radiat Oncol Biol Phys. 27:1993;537-544.
35. Brady L.W., Germon P.A., Cander L. The effects of radiotherapy on pulmonary function in carcinoma of the lung. Radiology. 85:1965;130-134.
36. Newton K.A., Spittle M.F. An analysis of 40 cases treated by total thoracic irradiation. Clin Radiol. 20:1969;19-22.
37. Whiters H.R., Taylor J.M.G., Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 14:1988;751-759.